Finally, AD pathology in this study was determined only by Aβ PET and tau PET to confirm its presence, without quantitative or regional characterization of deposition patterns, which may nonetheless relate to CR or depressive symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.